🇺🇸 FDA
Pipeline program

Insulin aspart

HALO-117-105

Phase 1 small_molecule completed

Quick answer

Insulin aspart for Type 1 Diabetes Mellitus is a Phase 1 program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
HALOZYME THERAPEUTICS, INC.
Indication
Type 1 Diabetes Mellitus
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials